Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 134 participants.
Also called NCT01522651
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 134 participants
- Sponsor
- Registry
-
NCT01522651 -
2011-001134-42
-
- Other papers using this trial's data
- The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Germany, Israel, Italy, Netherlands, Poland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01522651. Randomized; double masking; primary purpose treatment. Start 2012-01-24 (actual); primary completion 2014-03-10 (actual). Results posted on 2020-11-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation
- Acronym
- HARMONY
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Ranolazine
- Intervention (Drug)
- Dronedarone
- Intervention (Drug)
- Ranolazine placebo
- Intervention (Drug)
- Dronedarone placebo
- Lead sponsor
- Gilead Sciences
Record details
- Record id
cardio:ct-nct01522651- Content hash
f4188de39d36c09e4c8d07e7718c38864eaca7a070201088ecad5f2f39c7b499